Nutritional and Contractile Regulation of Muscle Growth
NCT ID: NCT00891696
Last Updated: 2017-05-04
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
PHASE1
Total Enrollment
144 participants
Study Classification
INTERVENTIONAL
Study Start Date
2009-04-30
Study Completion Date
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Muscle wasting, which involves the loss of muscle tissue, is common in many conditions, such as cancer, AIDS, trauma, kidney failure, bone fracture, and sepsis. It is also prevalent among the elderly and in people who experience periods of physical inactivity and weightlessness. Muscle wasting can lead to overall weakness, immobility, physical dependence, and a greater risk of death when exposed to infection, surgery, or trauma. There is a need to develop scientifically based treatments that prevent muscle wasting. As one step towards such a goal, this study will examine the physiological and cellular mechanisms that regulate skeletal muscle growth.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Insulin and Sarcopenia in the Elderly
NCT00690534
Sarcopenia
COMPLETED
PHASE1
Nutrition and Exercise for Sarcopenia
NCT00872911
Sarcopenia
COMPLETED
PHASE1
Muscle Perfusion and Protein Metabolism in Elderly
NCT00945256
Aging
COMPLETED
PHASE1
Molecular Mechanisms Underlying Anabolic Resistance to Protein Intake During Muscle Disuse
NCT06228742
Atrophy, Disuse
Muscle Atrophy
Muscular Disorders, Atrophic
+2 more
COMPLETED
NA
Combined Effects of Resistance Training and Nutritional Supplements in the Treatment of Sarcopenia
NCT00748696
Sarcopenia
TERMINATED
PHASE3
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Skeletal muscle comprises about 40% of one's body weight and contains about 50% to 75% of all the proteins in the human body. The turnover of protein is a regular process in the human body. In healthy adults, the interplay between muscle protein synthesis and muscle protein breakdown results in no net growth or loss of muscle mass. But when the scale tips towards muscle protein breakdown, muscle wasting can occur. This can result in negative consequences, because not only does muscle fill the obvious role of converting chemical energy into mechanical energy for moving and maintaining posture, but muscle is also involved in the following less apparent roles: regulating metabolism; removing potentially toxic substances from blood circulation; producing fuel for other tissues; storing energy and nitrogen, both of which are important for fueling the brain and immune system; and facilitating wound healing during malnutrition, starvation, injury, and disease. Therefore, muscle is important not only for physical independence but also for mere survival of the human body. In fact, a mere 30% loss of the body's proteins results in impaired respiration and circulation and can eventually lead to death. The purpose of this study is to examine the physiological and cellular mechanisms that regulate skeletal muscle growth. Results from the study may help to develop future treatments for maintaining and possibly increasing muscle mass as a way to improve function, reduce disease complications, and increase survival.
This study will enroll healthy participants who will be randomly assigned to one of several treatment arms within one of three separate experiments. Overall, the three experiments will examine the following: (1) whether the mammalian target of rapamycin (mTOR) signaling pathway--a group of molecules that work together to control a specific cellular function--is responsible for stimulating muscle protein synthesis after resistance exercise and/or ingestion of an amino acid supplement; (2) whether restricting blood flow with a blood pressure cuff during low-intensity resistance exercise ultimately leads to muscle protein synthesis; and (3) whether aging is associated with reduced physiological and cellular mechanisms that are related to muscle protein synthesis and whether such a reduction can be overcome by post-exercise ingestion of an amino acid supplement or blood flow restriction during low-intensity resistance exercise.
Depending on which treatment arm participants are assigned to, they may receive amino acid supplementation, the drug rapamycin, the drug sodium nitroprusside, and/or placebo. They may also undergo high-intensity resistance exercise, low-intensity resistance exercise, or low-intensity resistance exercise along with blood flow restriction. All participants will attend a single 8-hour study visit and a follow-up visit 1 week later. During the study visit, participants will undergo the following: measurements of vital signs, height, and weight; blood and urine sampling; a dual energy x-ray absorptiometry (DEXA) scan; and an infusion study that will include additional blood sampling, muscle biopsies, and assigned interventions. The follow-up visit will include evaluation of any incisions that were made during the infusion study.
This study will enroll healthy participants who will be randomly assigned to one of several treatment arms within one of three separate experiments. Overall, the three experiments will examine the following: (1) whether the mammalian target of rapamycin (mTOR) signaling pathway--a group of molecules that work together to control a specific cellular function--is responsible for stimulating muscle protein synthesis after resistance exercise and/or ingestion of an amino acid supplement; (2) whether restricting blood flow with a blood pressure cuff during low-intensity resistance exercise ultimately leads to muscle protein synthesis; and (3) whether aging is associated with reduced physiological and cellular mechanisms that are related to muscle protein synthesis and whether such a reduction can be overcome by post-exercise ingestion of an amino acid supplement or blood flow restriction during low-intensity resistance exercise.
Depending on which treatment arm participants are assigned to, they may receive amino acid supplementation, the drug rapamycin, the drug sodium nitroprusside, and/or placebo. They may also undergo high-intensity resistance exercise, low-intensity resistance exercise, or low-intensity resistance exercise along with blood flow restriction. All participants will attend a single 8-hour study visit and a follow-up visit 1 week later. During the study visit, participants will undergo the following: measurements of vital signs, height, and weight; blood and urine sampling; a dual energy x-ray absorptiometry (DEXA) scan; and an infusion study that will include additional blood sampling, muscle biopsies, and assigned interventions. The follow-up visit will include evaluation of any incisions that were made during the infusion study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Sarcopenia
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
FACTORIAL
Primary Study Purpose
BASIC_SCIENCE
Blinding Strategy
DOUBLE
Participants
Investigators
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exp 1: AA + Rap
Participants will receive amino acid supplementation and rapamycin.
Group Type
ACTIVE_COMPARATOR
Rapamycin
Intervention Type
DRUG
Single 16-mg oral dose
Amino acid supplementation
Intervention Type
OTHER
Nutritional drink containing essential amino acids
Exp 1: AA
Participants will receive amino acid supplementation and placebo rapamycin.
Group Type
PLACEBO_COMPARATOR
Amino acid supplementation
Intervention Type
OTHER
Nutritional drink containing essential amino acids
Exp 1: HEx + Rap
Participants will receive rapamycin and placebo amino acid supplementation, and they will undergo high-intensity resistance exercise.
Group Type
ACTIVE_COMPARATOR
Rapamycin
Intervention Type
DRUG
Single 16-mg oral dose
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 1: HEx
Participants will receive placebo amino acid supplementation and placebo rapamycin, and they will undergo high-intensity resistance exercise.
Group Type
PLACEBO_COMPARATOR
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 1: HEx + AA + Rap
Participants will receive amino acid supplementation and rapamycin, and they will undergo high-intensity resistance exercise.
Group Type
ACTIVE_COMPARATOR
Rapamycin
Intervention Type
DRUG
Single 16-mg oral dose
Amino acid supplementation
Intervention Type
OTHER
Nutritional drink containing essential amino acids
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 1: HEx + AA
Participants will receive amino acid supplementation and placebo rapamycin, and they will undergo high-intensity resistance exercise.
Group Type
PLACEBO_COMPARATOR
Amino acid supplementation
Intervention Type
OTHER
Nutritional drink containing essential amino acids
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 2: LExFR + Rap
Participants will receive rapamycin and will undergo low-intensity resistance exercise with blood flow restriction.
Group Type
ACTIVE_COMPARATOR
Rapamycin
Intervention Type
DRUG
Single 16-mg oral dose
Blood flow restriction cuff
Intervention Type
DEVICE
Blood flow restriction for 5 minutes after the second biopsy
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 2 and 3: LExFR
Participants will receive placebo rapamycin and will undergo low-intensity resistance exercise with blood flow restriction.
Group Type
PLACEBO_COMPARATOR
Blood flow restriction cuff
Intervention Type
DEVICE
Blood flow restriction for 5 minutes after the second biopsy
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 2: SNP
Participants will receive sodium nitroprusside in a resting state.
Group Type
ACTIVE_COMPARATOR
Sodium nitroprusside
Intervention Type
DRUG
Variable rate for 3 hours
Exp 2: FR
Participants will undergo blood flow restriction in a resting state.
Group Type
ACTIVE_COMPARATOR
Blood flow restriction cuff
Intervention Type
DEVICE
Blood flow restriction for 5 minutes after the second biopsy
Exp 2: LEx + SNP
Participants will receive sodium nitroprusside and undergo low-intensity resistance exercise.
Group Type
ACTIVE_COMPARATOR
Sodium nitroprusside
Intervention Type
DRUG
Variable rate for 3 hours
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 3: LEx
Participants will undergo low-intensity resistance exercise.
Group Type
PLACEBO_COMPARATOR
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 3: HEx
Participants will undergo high-intensity resistance exercise.
Group Type
ACTIVE_COMPARATOR
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Exp 3: HEx + AA
Participants will receive amino acid supplementation and will undergo high-intensity resistance exercise.
Group Type
ACTIVE_COMPARATOR
Low-intensity resistance exercise
Intervention Type
OTHER
Leg extension exercises on a Cybex leg extension machine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rapamycin
Single 16-mg oral dose
Intervention Type
DRUG
Amino acid supplementation
Nutritional drink containing essential amino acids
Intervention Type
OTHER
Low-intensity resistance exercise
Leg extension exercises on a Cybex leg extension machine
Intervention Type
OTHER
Sodium nitroprusside
Variable rate for 3 hours
Intervention Type
DRUG
Blood flow restriction cuff
Blood flow restriction for 5 minutes after the second biopsy
Intervention Type
DEVICE
Low-intensity resistance exercise
Leg extension exercises on a Cybex leg extension machine
Intervention Type
OTHER
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
KAATSU cuff
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 35 years of age for the young groups
* 60 to 85 years of age for the older groups
* In the follicular phase for the young women participants
* Ability to sign consent form, as based on a score of greater than 25 on the 30-item Mini Mental State Examination (MMSE)
* Stable body weight for at least 1 year
* 60 to 85 years of age for the older groups
* In the follicular phase for the young women participants
* Ability to sign consent form, as based on a score of greater than 25 on the 30-item Mini Mental State Examination (MMSE)
* Stable body weight for at least 1 year
Exclusion Criteria
* Physical dependence or frailty, as determined by impairment in any of the activities of daily living (ADLs), history of more than two falls per year, or significant weight loss in the past year
* Exercise training that consists of more than two weekly sessions of moderate to high intensity aerobic or resistance exercise
* Significant heart, liver, kidney, blood, or respiratory disease
* Peripheral vascular disease
* Diabetes mellitus or other untreated endocrine disease
* Active cancer
* History of cancer for participants who may be randomly assigned to rapamycin)
* Acute infectious disease or history of chronic infections (e.g., tuberculosis, hepatitis, HIV, herpes)
* Treatment with anabolic steroids or corticosteroids within 6 months of study entry
* Alcohol or drug abuse
* Tobacco use (smoking or chewing)
* Malnutrition (e.g., body mass index \[BMI\] less than 20 kg/m2, hypoalbuminemia, and/or hypotransferrinemia)
* Obesity (BMI greater than 30 kg/m2)
* Lower than normal hemoglobin levels
* Exercise training that consists of more than two weekly sessions of moderate to high intensity aerobic or resistance exercise
* Significant heart, liver, kidney, blood, or respiratory disease
* Peripheral vascular disease
* Diabetes mellitus or other untreated endocrine disease
* Active cancer
* History of cancer for participants who may be randomly assigned to rapamycin)
* Acute infectious disease or history of chronic infections (e.g., tuberculosis, hepatitis, HIV, herpes)
* Treatment with anabolic steroids or corticosteroids within 6 months of study entry
* Alcohol or drug abuse
* Tobacco use (smoking or chewing)
* Malnutrition (e.g., body mass index \[BMI\] less than 20 kg/m2, hypoalbuminemia, and/or hypotransferrinemia)
* Obesity (BMI greater than 30 kg/m2)
* Lower than normal hemoglobin levels
Minimum Eligible Age
18 Years
Maximum Eligible Age
85 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
Sponsor Role
collaborator
The University of Texas Medical Branch, Galveston
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Blake Rasmussen, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Medical Branch, Galveston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutrition & Metabolism, University of Texas Medical Branch
Galveston, Texas, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Fry CS, Drummond MJ, Glynn EL, Dickinson JM, Gundermann DM, Timmerman KL, Walker DK, Dhanani S, Volpi E, Rasmussen BB. Aging impairs contraction-induced human skeletal muscle mTORC1 signaling and protein synthesis. Skelet Muscle. 2011 Mar 2;1(1):11. doi: 10.1186/2044-5040-1-11.
Reference Type
RESULT
Gundermann DM, Fry CS, Dickinson JM, Walker DK, Timmerman KL, Drummond MJ, Volpi E, Rasmussen BB. Reactive hyperemia is not responsible for stimulating muscle protein synthesis following blood flow restriction exercise. J Appl Physiol (1985). 2012 May;112(9):1520-8. doi: 10.1152/japplphysiol.01267.2011. Epub 2012 Feb 23.
Reference Type
RESULT
Walker DK, Fry CS, Drummond MJ, Dickinson JM, Timmerman KL, Gundermann DM, Jennings K, Volpi E, Rasmussen BB. PAX7+ satellite cells in young and older adults following resistance exercise. Muscle Nerve. 2012 Jul;46(1):51-9. doi: 10.1002/mus.23266. Epub 2012 May 29.
Reference Type
RESULT
Fujita S, Dreyer HC, Drummond MJ, Glynn EL, Volpi E, Rasmussen BB. Essential amino acid and carbohydrate ingestion before resistance exercise does not enhance postexercise muscle protein synthesis. J Appl Physiol (1985). 2009 May;106(5):1730-9. doi: 10.1152/japplphysiol.90395.2008. Epub 2008 Jun 5.
Reference Type
RESULT
Volpi E, Chinkes DL, Rasmussen BB. Sequential muscle biopsies during a 6-h tracer infusion do not affect human mixed muscle protein synthesis and muscle phenylalanine kinetics. Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E959-63. doi: 10.1152/ajpendo.00671.2007. Epub 2008 Aug 19.
Reference Type
RESULT
Drummond MJ, Miyazaki M, Dreyer HC, Pennings B, Dhanani S, Volpi E, Esser KA, Rasmussen BB. Expression of growth-related genes in young and older human skeletal muscle following an acute stimulation of protein synthesis. J Appl Physiol (1985). 2009 Apr;106(4):1403-11. doi: 10.1152/japplphysiol.90842.2008. Epub 2008 Sep 11.
Reference Type
RESULT
Drummond MJ, McCarthy JJ, Fry CS, Esser KA, Rasmussen BB. Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1333-40. doi: 10.1152/ajpendo.90562.2008. Epub 2008 Sep 30.
Reference Type
RESULT
Drummond MJ, Fry CS, Glynn EL, Dreyer HC, Dhanani S, Timmerman KL, Volpi E, Rasmussen BB. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J Physiol. 2009 Apr 1;587(Pt 7):1535-46. doi: 10.1113/jphysiol.2008.163816. Epub 2009 Feb 2.
Reference Type
RESULT
Drummond MJ, Glynn EL, Fry CS, Dhanani S, Volpi E, Rasmussen BB. Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle. J Nutr. 2009 Dec;139(12):2279-84. doi: 10.3945/jn.109.112797. Epub 2009 Oct 14.
Reference Type
RESULT
Dreyer HC, Fujita S, Glynn EL, Drummond MJ, Volpi E, Rasmussen BB. Resistance exercise increases leg muscle protein synthesis and mTOR signalling independent of sex. Acta Physiol (Oxf). 2010 May;199(1):71-81. doi: 10.1111/j.1748-1716.2010.02074.x. Epub 2010 Jan 12.
Reference Type
RESULT
Fry CS, Glynn EL, Drummond MJ, Timmerman KL, Fujita S, Abe T, Dhanani S, Volpi E, Rasmussen BB. Blood flow restriction exercise stimulates mTORC1 signaling and muscle protein synthesis in older men. J Appl Physiol (1985). 2010 May;108(5):1199-209. doi: 10.1152/japplphysiol.01266.2009. Epub 2010 Feb 11.
Reference Type
RESULT
Drummond MJ, Glynn EL, Fry CS, Timmerman KL, Volpi E, Rasmussen BB. An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. Am J Physiol Endocrinol Metab. 2010 May;298(5):E1011-8. doi: 10.1152/ajpendo.00690.2009. Epub 2010 Feb 9.
Reference Type
RESULT
Glynn EL, Fry CS, Drummond MJ, Dreyer HC, Dhanani S, Volpi E, Rasmussen BB. Muscle protein breakdown has a minor role in the protein anabolic response to essential amino acid and carbohydrate intake following resistance exercise. Am J Physiol Regul Integr Comp Physiol. 2010 Aug;299(2):R533-40. doi: 10.1152/ajpregu.00077.2010. Epub 2010 Jun 2.
Reference Type
RESULT
Glynn EL, Fry CS, Drummond MJ, Timmerman KL, Dhanani S, Volpi E, Rasmussen BB. Excess leucine intake enhances muscle anabolic signaling but not net protein anabolism in young men and women. J Nutr. 2010 Nov;140(11):1970-6. doi: 10.3945/jn.110.127647. Epub 2010 Sep 15.
Reference Type
RESULT
Drummond MJ, McCarthy JJ, Sinha M, Spratt HM, Volpi E, Esser KA, Rasmussen BB. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol Genomics. 2011 May 1;43(10):595-603. doi: 10.1152/physiolgenomics.00148.2010. Epub 2010 Sep 28.
Reference Type
RESULT
Dickinson JM, Fry CS, Drummond MJ, Gundermann DM, Walker DK, Glynn EL, Timmerman KL, Dhanani S, Volpi E, Rasmussen BB. Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids. J Nutr. 2011 May;141(5):856-62. doi: 10.3945/jn.111.139485. Epub 2011 Mar 23.
Reference Type
RESULT
Drummond MJ, Fry CS, Glynn EL, Timmerman KL, Dickinson JM, Walker DK, Gundermann DM, Volpi E, Rasmussen BB. Skeletal muscle amino acid transporter expression is increased in young and older adults following resistance exercise. J Appl Physiol (1985). 2011 Jul;111(1):135-42. doi: 10.1152/japplphysiol.01408.2010. Epub 2011 Apr 28.
Reference Type
RESULT
Dickinson JM, Drummond MJ, Coben JR, Volpi E, Rasmussen BB. Aging differentially affects human skeletal muscle amino acid transporter expression when essential amino acids are ingested after exercise. Clin Nutr. 2013 Apr;32(2):273-80. doi: 10.1016/j.clnu.2012.07.009. Epub 2012 Aug 1.
Reference Type
RESULT
Fry CS, Drummond MJ, Lujan HL, DiCarlo SE, Rasmussen BB. Paraplegia increases skeletal muscle autophagy. Muscle Nerve. 2012 Nov;46(5):793-8. doi: 10.1002/mus.23423.
Reference Type
RESULT
Fry CS, Drummond MJ, Glynn EL, Dickinson JM, Gundermann DM, Timmerman KL, Walker DK, Volpi E, Rasmussen BB. Skeletal muscle autophagy and protein breakdown following resistance exercise are similar in younger and older adults. J Gerontol A Biol Sci Med Sci. 2013 May;68(5):599-607. doi: 10.1093/gerona/gls209. Epub 2012 Oct 22.
Reference Type
RESULT
Reidy PT, Walker DK, Dickinson JM, Gundermann DM, Drummond MJ, Timmerman KL, Fry CS, Borack MS, Cope MB, Mukherjea R, Jennings K, Volpi E, Rasmussen BB. Protein blend ingestion following resistance exercise promotes human muscle protein synthesis. J Nutr. 2013 Apr;143(4):410-6. doi: 10.3945/jn.112.168021. Epub 2013 Jan 23.
Reference Type
RESULT
Glynn EL, Fry CS, Timmerman KL, Drummond MJ, Volpi E, Rasmussen BB. Addition of carbohydrate or alanine to an essential amino acid mixture does not enhance human skeletal muscle protein anabolism. J Nutr. 2013 Mar;143(3):307-14. doi: 10.3945/jn.112.168203. Epub 2013 Jan 23.
Reference Type
RESULT
Drummond MJ, Dickinson JM, Fry CS, Walker DK, Gundermann DM, Reidy PT, Timmerman KL, Markofski MM, Paddon-Jones D, Rasmussen BB, Volpi E. Bed rest impairs skeletal muscle amino acid transporter expression, mTORC1 signaling, and protein synthesis in response to essential amino acids in older adults. Am J Physiol Endocrinol Metab. 2012 May 15;302(9):E1113-22. doi: 10.1152/ajpendo.00603.2011. Epub 2012 Feb 14.
Reference Type
RESULT
Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):86-90. doi: 10.1097/MCO.0b013e32831cef8b.
Reference Type
RESULT
Drummond MJ, Dreyer HC, Fry CS, Glynn EL, Rasmussen BB. Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling. J Appl Physiol (1985). 2009 Apr;106(4):1374-84. doi: 10.1152/japplphysiol.91397.2008. Epub 2009 Jan 15.
Reference Type
RESULT
Dickinson JM, Rasmussen BB. Essential amino acid sensing, signaling, and transport in the regulation of human muscle protein metabolism. Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):83-8. doi: 10.1097/MCO.0b013e3283406f3e.
Reference Type
RESULT
Fry CS, Rasmussen BB. Skeletal muscle protein balance and metabolism in the elderly. Curr Aging Sci. 2011 Dec;4(3):260-8. doi: 10.2174/1874609811104030260.
Reference Type
RESULT
Walker DK, Dickinson JM, Timmerman KL, Drummond MJ, Reidy PT, Fry CS, Gundermann DM, Rasmussen BB. Exercise, amino acids, and aging in the control of human muscle protein synthesis. Med Sci Sports Exerc. 2011 Dec;43(12):2249-58. doi: 10.1249/MSS.0b013e318223b037.
Reference Type
RESULT
Bell JA, Fujita S, Volpi E, Cadenas JG, Rasmussen BB. Short-term insulin and nutritional energy provision do not stimulate muscle protein synthesis if blood amino acid availability decreases. Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E999-1006. doi: 10.1152/ajpendo.00170.2005. Epub 2005 Jul 19.
Reference Type
RESULT
Bell JA, Volpi E, Fujita S, Cadenas JG, Sheffield-Moore M, Rasmussen BB. Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes. J Nutr. 2006 May;136(5):1249-55. doi: 10.1093/jn/136.5.1249.
Reference Type
RESULT
Dreyer HC, Fujita S, Cadenas JG, Chinkes DL, Volpi E, Rasmussen BB. Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle. J Physiol. 2006 Oct 15;576(Pt 2):613-24. doi: 10.1113/jphysiol.2006.113175. Epub 2006 Jul 27.
Reference Type
RESULT
Fujita S, Rasmussen BB, Bell JA, Cadenas JG, Volpi E. Basal muscle intracellular amino acid kinetics in women and men. Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E77-83. doi: 10.1152/ajpendo.00173.2006. Epub 2006 Aug 8.
Reference Type
RESULT
Fujita S, Rasmussen BB, Cadenas JG, Drummond MJ, Glynn EL, Sattler FR, Volpi E. Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes. 2007 Jun;56(6):1615-22. doi: 10.2337/db06-1566. Epub 2007 Mar 9.
Reference Type
RESULT
Fujita S, Dreyer HC, Drummond MJ, Glynn EL, Cadenas JG, Yoshizawa F, Volpi E, Rasmussen BB. Nutrient signalling in the regulation of human muscle protein synthesis. J Physiol. 2007 Jul 15;582(Pt 2):813-23. doi: 10.1113/jphysiol.2007.134593. Epub 2007 May 3.
Reference Type
RESULT
Fujita S, Abe T, Drummond MJ, Cadenas JG, Dreyer HC, Sato Y, Volpi E, Rasmussen BB. Blood flow restriction during low-intensity resistance exercise increases S6K1 phosphorylation and muscle protein synthesis. J Appl Physiol (1985). 2007 Sep;103(3):903-10. doi: 10.1152/japplphysiol.00195.2007. Epub 2007 Jun 14.
Reference Type
RESULT
Dreyer HC, Glynn EL, Lujan HL, Fry CS, DiCarlo SE, Rasmussen BB. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway. J Appl Physiol (1985). 2008 Jan;104(1):27-33. doi: 10.1152/japplphysiol.00736.2007. Epub 2007 Sep 20.
Reference Type
RESULT
Glynn EL, Lujan HL, Kramer VJ, Drummond MJ, DiCarlo SE, Rasmussen BB. A chronic increase in physical activity inhibits fed-state mTOR/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle. Appl Physiol Nutr Metab. 2008 Feb;33(1):93-101. doi: 10.1139/H07-149.
Reference Type
RESULT
Dreyer HC, Drummond MJ, Pennings B, Fujita S, Glynn EL, Chinkes DL, Dhanani S, Volpi E, Rasmussen BB. Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E392-400. doi: 10.1152/ajpendo.00582.2007. Epub 2007 Dec 4.
Reference Type
RESULT
Drummond MJ, Glynn EL, Lujan HL, Dicarlo SE, Rasmussen BB. Gene and protein expression associated with protein synthesis and breakdown in paraplegic skeletal muscle. Muscle Nerve. 2008 Apr;37(4):505-13. doi: 10.1002/mus.20976.
Reference Type
RESULT
Drummond MJ, Fujita S, Abe T, Dreyer HC, Volpi E, Rasmussen BB. Human muscle gene expression following resistance exercise and blood flow restriction. Med Sci Sports Exerc. 2008 Apr;40(4):691-8. doi: 10.1249/MSS.0b013e318160ff84.
Reference Type
RESULT
Drummond MJ, Bell JA, Fujita S, Dreyer HC, Glynn EL, Volpi E, Rasmussen BB. Amino acids are necessary for the insulin-induced activation of mTOR/S6K1 signaling and protein synthesis in healthy and insulin resistant human skeletal muscle. Clin Nutr. 2008 Jun;27(3):447-56. doi: 10.1016/j.clnu.2008.01.012. Epub 2008 Mar 14.
Reference Type
RESULT
Drummond MJ, Dreyer HC, Pennings B, Fry CS, Dhanani S, Dillon EL, Sheffield-Moore M, Volpi E, Rasmussen BB. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol (1985). 2008 May;104(5):1452-61. doi: 10.1152/japplphysiol.00021.2008. Epub 2008 Mar 6.
Reference Type
RESULT
Dreyer HC, Drummond MJ, Glynn EL, Fujita S, Chinkes DL, Volpi E, Rasmussen BB. Resistance exercise increases human skeletal muscle AS160/TBC1D4 phosphorylation in association with enhanced leg glucose uptake during postexercise recovery. J Appl Physiol (1985). 2008 Dec;105(6):1967-74. doi: 10.1152/japplphysiol.90562.2008. Epub 2008 Oct 9.
Reference Type
RESULT
Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis. Curr Opin Clin Nutr Metab Care. 2008 May;11(3):222-6. doi: 10.1097/MCO.0b013e3282fa17fb.
Reference Type
RESULT
Borack MS, Dickinson JM, Fry CS, Reidy PT, Markofski MM, Deer RR, Jennings K, Volpi E, Rasmussen BB. Effect of the lysosomotropic agent chloroquine on mTORC1 activation and protein synthesis in human skeletal muscle. Nutr Metab (Lond). 2021 Jun 12;18(1):61. doi: 10.1186/s12986-021-00585-w.
Reference Type
DERIVED
Graber TG, Borack MS, Reidy PT, Volpi E, Rasmussen BB. Essential amino acid ingestion alters expression of genes associated with amino acid sensing, transport, and mTORC1 regulation in human skeletal muscle. Nutr Metab (Lond). 2017 May 11;14:35. doi: 10.1186/s12986-017-0187-1. eCollection 2017.
Reference Type
DERIVED
Dickinson JM, Gundermann DM, Walker DK, Reidy PT, Borack MS, Drummond MJ, Arora M, Volpi E, Rasmussen BB. Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men. J Nutr. 2014 Nov;144(11):1694-702. doi: 10.3945/jn.114.198671. Epub 2014 Sep 3.
Reference Type
DERIVED
Dickinson JM, Drummond MJ, Fry CS, Gundermann DM, Walker DK, Timmerman KL, Volpi E, Rasmussen BB. Rapamycin does not affect post-absorptive protein metabolism in human skeletal muscle. Metabolism. 2013 Jan;62(1):144-51. doi: 10.1016/j.metabol.2012.07.003. Epub 2012 Sep 6.
Reference Type
DERIVED
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Can Supplemental Leucine Offset Disuse-induced Muscle Atrophy?
NCT03762278
COMPLETED
NA
Preserving Muscle Mass and Function in Bedridden Older Adults
NCT01846130
COMPLETED
NA
Leucine Supplementation and Skeletal Muscle Disuse
NCT01192009
COMPLETED
NA
Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors
NCT02501460
COMPLETED
NA
The Effect of Nandrolone Decanoate and Leucine on Muscle Loss
NCT02376309
COMPLETED
NA
Effect of a Natural Source Supplementation on Muscle Mass
NCT05369026
COMPLETED
NA
Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age
NCT06567665
RECRUITING
NA
Amino Acid Metabolism in Fed Surgical Critically Ill Patients
NCT03451968
UNKNOWN
NA
Muscle Response to Different Amounts of Dietary Protein During Leg Immobilization
NCT07069426
RECRUITING
NA
The Role of Muscle Protein Breakdown in the Regulation of Muscle Quality in Frail Elderly Individuals
NCT03326648
COMPLETED
NA
Nutrition Ameliorates the Muscle Loss of Pre-sarcopenia in Elderly
NCT07309120
COMPLETED
NA
Counteracting Age-related Loss of Skeletal Muscle Mass
NCT02034760
COMPLETED
NA
Nutritional Intervention for Sarcopenia
NCT03891134
COMPLETED
NA
The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults.
NCT04900701
ACTIVE_NOT_RECRUITING
NA
Assessing the Dose-response of Muscle Protein Synthesis to "Super-whey" in Older Adults
NCT05700058
UNKNOWN
NA
Optimization of the Preservation of Muscle Mass and / or Its Recovery by a Protein-energy Chrononutrition Approach Dissociated From Meals
NCT03867006
TERMINATED
NA
Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients
NCT02990533
COMPLETED
PHASE1
Muscle Mass During Space Exploration
NCT00968344
COMPLETED
NA
Leucine Co-ingestion and Myofibrillar Protein Synthesis in Older Adults
NCT02371278
COMPLETED
NA
Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone
NCT01057680
COMPLETED
PHASE3
Nutritional Biomarkers of Sarcopenia
NCT05117112
COMPLETED
NA
Effects of Short-term Energy Deficit on Muscle Protein Turnover
NCT02406040
COMPLETED
NA
Muscle Protein Metabolism in Obesity
NCT01824173
COMPLETED
PHASE1
Determining the Muscle Anabolic Properties of Phosphatidic Acid.
NCT03446924
COMPLETED
NA
Dietary Supplements and Aging Muscle
NCT01057082
COMPLETED
NA